Decoy Therapeutics is trading at $1.09, up 5.83%, with biotech sector strength the likeliest available explanation, not a confirmed company catalyst.
- Biotech ETF XBI rose 2.18% during the regular session; the broader major-index picture was mixed.
- Search results showed no company-specific announcement explaining the October 28 move. The latest company news located was dated September 29.